Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

General Screening for Eligibility to Participate in Treatment, Prevention and Vaccine Trials at the Seattle Malaria Clinical Trials Center

NCT02119312 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT02119312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02119312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
General Screening for Eligibility to Participate in Treatment, Prevention and Vaccine Trials at the Seattle Malaria Clinical Trials Center
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
September 1, 2020
Enrollment
2,101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria